GERN - Geron Corporation

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
1.97
-0.04 (-1.99%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close2.01
Open2.01
Bid0.00 x 0
Ask0.00 x 0
Day's Range1.95 - 2.03
52 Week Range1.74 - 3.15
Volume1,441,239
Avg. Volume1,274,200
Market Cap313.687M
Beta2.51
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • 5 Biotech Buyout Candidates for 2018
    Motley Fool2 days ago

    5 Biotech Buyout Candidates for 2018

    The Republican-inspired U.S. tax reform could spur an acquisition bonanza in biotech next year. Here's a look at five companies that might be prime targets.

  • 3 Top Healthcare Stocks to Buy in December
    Motley Fool3 days ago

    3 Top Healthcare Stocks to Buy in December

    Now could be the perfect time to add to your portfolio healthcare stocks that can benefit from aging baby boomers and regulatory approvals.

  • 3 Stocks to Hold for the Next 20 Years
    Motley Fool4 days ago

    3 Stocks to Hold for the Next 20 Years

    If you're looking for long-term stocks to buy, check out this trio that look primed for outperformance.

  • Capital Cube8 days ago

    ETFs with exposure to Geron Corp. : December 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Geron Corp. Here are 5 ETFs with the largest exposure to GERN-US. Comparing the performance and risk of Geron Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • 2 Reasons Geron Corporation Took a Pounding in November
    Motley Fool9 days ago

    2 Reasons Geron Corporation Took a Pounding in November

    Can these concerns be overlooked?

  • 1 High-Risk Penny Stock That May Be Worth Buying
    Motley Fool10 days ago

    1 High-Risk Penny Stock That May Be Worth Buying

    The market might be dead wrong about clinical-stage cancer company Geron, which gives risk-tolerant investors the potential for explosive gains.

  • Capital Cube18 days ago

    ETFs with exposure to Geron Corp. : November 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Geron Corp. Here are 5 ETFs with the largest exposure to GERN-US. Comparing the performance and risk of Geron Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube28 days ago

    ETFs with exposure to Geron Corp. : November 17, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Geron Corp. Here are 5 ETFs with the largest exposure to GERN-US. Comparing the performance and risk of Geron Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Benzingalast month

    9 Notable Biotechs Presenting At This Year's ASH Meeting

    One of the biggest biotech conferences of the year is around the corner. The 59th annual meeting of the American Society of Hematology, or ASH, is Dec. 9-12 in Atlanta. It's likely to serve as a make-or-break ...

  • Thomson Reuters StreetEventslast month

    Edited Transcript of GERN earnings conference call or presentation 1-Nov-17 8:30pm GMT

    Q3 2017 Geron Corp Earnings Call

  • Capital Cubelast month

    ETFs with exposure to Geron Corp. : November 6, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Geron Corp. Here are 5 ETFs with the largest exposure to GERN-US. Comparing the performance and risk of Geron Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Geron Corp. :GERN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017
    Capital Cubelast month

    Geron Corp. :GERN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017

    Categories: Yahoo FinanceGet free summary analysis Geron Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Geron Corp. – Gilead Sciences, Inc., Bio-Techne Corporation and Incyte Corporation (GILD-US, TECH-US and INCY-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 0.16 ... Read more (Read more...)

  • Capital Cubelast month

    Geron Corp. – Value Analysis (NASDAQ:GERN) : November 2, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Geron Corp. a score of 43. Our analysis is based on comparing Geron Corp. with the following peers – BioTime, Inc., Gilead Sciences, Inc., CTI BioPharma Corp., Bio-Techne Corporation, Microbot Medical Inc, Stemline Therapeutics, Inc., Immunomedics, Inc., Incyte Corporation, Osiris Therapeutics, Inc. and Neuralstem, Inc. (BTX-US, GILD-US, ... Read more (Read more...)

  • Geron (GERN) Q3 Loss Narrower Than Expected, Sales Miss
    Zackslast month

    Geron (GERN) Q3 Loss Narrower Than Expected, Sales Miss

    Geron's (GERN) loss per share in the third quarter was narrower than expected. However, revenues missed estimates. Imetelstat remains in focus.

  • Associated Presslast month

    Geron reports 3Q loss

    The Menlo Park, California-based company said it had a loss of 4 cents per share. The drugmaker posted revenue of $163,000 in the period. In the final minutes of trading on Wednesday, the company's shares ...

  • Geron (GERN) in Focus: Stock Moves 9.2% Higher
    Zackslast month

    Geron (GERN) in Focus: Stock Moves 9.2% Higher

    Geron (GERN) saw its shares rise over 9% on the day after the company received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its experimental blood-cancer medicine, imetelstat.

  • Geron Corp. breached its 50 day moving average in a Bullish Manner : GERN-US : November 1, 2017
    Capital Cubelast month

    Geron Corp. breached its 50 day moving average in a Bullish Manner : GERN-US : November 1, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Geron Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...)

  • Why Geron Corporation Stock Is Jumping Today
    Motley Foollast month

    Why Geron Corporation Stock Is Jumping Today

    Geron and Johnson & Johnson's experimental blood-cancer drug may end up living up to the hype after all.

  • TheStreet.comlast month

    Geron Shares Rise on Fast Track Designation -- Biotech Movers

    The FDA granted fast track designation to imetelstat as a potential treatment for adults with with transfusion-dependent anemia.

  • 3 Stocks With Microsoft-like Return Potential
    Motley Foollast month

    3 Stocks With Microsoft-like Return Potential

    Join us as we try to catch lightning in a bottle -- again.

  • What's in the Cards for Geron (GERN) this Earnings Season?
    Zacks2 months ago

    What's in the Cards for Geron (GERN) this Earnings Season?

    With no approved product in Geron's (GERN) portfolio, investor focus is likely to remain on its sole pipeline candidate, imetelstat, in the Q3 release.

  • Capital Cube2 months ago

    ETFs with exposure to Geron Corp. : October 13, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Geron Corp. Here are 5 ETFs with the largest exposure to GERN-US. Comparing the performance and risk of Geron Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Geron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : October 4, 2017
    Capital Cube2 months ago

    Geron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : October 4, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Geron Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...)

  • Capital Cube2 months ago

    ETFs with exposure to Geron Corp. : October 2, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Geron Corp. Here are 5 ETFs with the largest exposure to GERN-US. Comparing the performance and risk of Geron Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube3 months ago

    ETFs with exposure to Geron Corp. : September 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Geron Corp. Here are 5 ETFs with the largest exposure to GERN-US. Comparing the performance and risk of Geron Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)